ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0254

Microvascular and Cutaneous Assessment in Adult Patients with Hypermobile Ehlers-Danlos Syndrome

Alberto Sulli1, Francesca Lalli2, Elvis Hysa2, Andrea Cere1, Alessandro Pinelli2, Silvia Sammorì1, Emanuele Gotelli1, Carmen Pizzorni1, Marco Castori3, Fransiska Malfait4, Vanessa Smith5 and Maurizio Cutolo6, 1Laboratory of Experimental Rheumatology and Academic Division of Rheumatology, Department of Internal Medicine, University of Genoa, IRCCS San Martino Polyclinic Hospital, Genoa, Italy, 2Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS San Martino Polyclinic Hospital, Genova, Italy, 3Division of Medical Genetics, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy, 4Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium, 5Ghent University Hospital, Gent, Belgium, 6Laboratory of Experimental Rheumatology, Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS San Martino Polyclinic, Genova, Italy

Meeting: ACR Convergence 2023

Keywords: Ehlers-Danlos, skin

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0252–0282) Miscellaneous Rheumatic & Inflammatory Diseases Poster I

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Hypermobile Ehlers-Danlos syndrome (hEDS) is a hereditary connective tissue disease characterized by joint hypermobility, chronic musculoskeletal pain, and systemic manifestations, primarily caused by defects in collagen synthesis or processing [1]. The microvascular morphology and functional status have not been evaluated in hEDS, as well as dermal thickness (DT) has been little investigated.
The aim of this study was to examine the nailfold microvascular morphological status, assess peripheral blood perfusion (PBP) and measure dermal thickness (DT) in patients with hEDS in comparison with sex and age-matched healthy controls (CNT).

Methods: Twelve patients diagnosed with hEDS (mean age 40±15, 75% females), classified according to the 2017 International Classification Criteria of EDS [2], were included in the study. Twelve age- and sex-matched CNT were also recruited. The Beighton score was calculated for both hEDS patients and CNT, to assess joint hypermobility. The main parameters derived from nailfold videocapillaroscopy (NVC), including dilated capillaries, giant capillaries, microhemorrhages, abnormal capillary shapes, and capillary count, were analysed and compared between the two groups to assess morphological features [3]. Furthermore, the microvascular functional status was evaluated using laser speckle contrast analysis (LASCA), measuring peripheral blood perfusion (PBP) in various regions of interest of the hand. DT was assessed by cross-sectional B-mode scans acquired using a high-frequency 22 MHz ultrasound probe, analysing seventeen different body areas, such as the upper arms, lower arms, trunk, and forehead.

Results: Microhemorrhages were found more prevalent in hEDS patients (25% vs 0%, p = 0.09), the capillary number per linear millimetre at the nailfold was slightly higher in hEDS patients than in CNT, as well as the NVC score for abnormal shaped capillaries was slightly lower (less abnormal shaped capillaries) in hEDS patients than in CNT. PBP was similar between hEDS patients and CNT. The DT resulted generally lower in hEDS patients than controls with significant values limited to feet and thorax (p=0.04). A statistically significant positive correlation was observed between the Beighton score and the score for microhemorrhages (r=0.4, p=0.05), as well as between the Beighton score and DT (r≥0.5, p≤0.02) at the level of feet and thorax.

Conclusion: Our study demonstrates that hEDS patients exhibit a morphologically suitable capillary morphology and normal microvascular function during resting conditions. However, there is a increased microvascular fragility in these patients. Additionally, we observed that dermal thickness appears thinner in hEDS patients compared to controls across most skin areas, with significant differences noted in the feet and thorax regions.

References: [1] Malfait F et al.Nat Rev Dis Primers. 2020. [2] Malfait F et al. Am J Med Genet C Semin Med Genet 2017. [3] Smith et al. Autoimmun Rev 2020.


Disclosures: A. Sulli: None; F. Lalli: None; E. Hysa: None; A. Cere: None; A. Pinelli: None; S. Sammorì: None; E. Gotelli: None; C. Pizzorni: None; M. Castori: None; F. Malfait: None; V. Smith: Boehringer Ingelheim, 2, 5, 6, 12, Support for travel, Galapagos, 6, Janssen-Cilag, 1, 2, 5, 6; M. Cutolo: Amgen, 5, Boehringer Ingelheim, 5, Bristol-Myers Squibb, 5, Lab.Baldacci, 5.

To cite this abstract in AMA style:

Sulli A, Lalli F, Hysa E, Cere A, Pinelli A, Sammorì S, Gotelli E, Pizzorni C, Castori M, Malfait F, Smith V, Cutolo M. Microvascular and Cutaneous Assessment in Adult Patients with Hypermobile Ehlers-Danlos Syndrome [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/microvascular-and-cutaneous-assessment-in-adult-patients-with-hypermobile-ehlers-danlos-syndrome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/microvascular-and-cutaneous-assessment-in-adult-patients-with-hypermobile-ehlers-danlos-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology